Dr. Linda Duska, MD
Claim this profileUniversity of Virginia Cancer Center
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
24 reported clinical trials
37 drugs studied
About Linda Duska, MD
Education:
- Obtained MD from the University of Virginia School of Medicine in 1995.
- Completed Residency in Obstetrics and Gynecology at the University of Virginia Health System in 2000.
- Finished Fellowship in Gynecologic Oncology at the University of Virginia Health System in 2003.
Experience:
- Currently a Professor of Obstetrics and Gynecology at the University of Virginia School of Medicine.
- Serves as the Director of the Division of Gynecologic Oncology at the University of Virginia Cancer Center.
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
ARID1A positive
Stage III
2Fallopian Tube Cancer
Stage III
Stage IV
DDR deficiency positive
Affiliated Hospitals
Clinical Trials Linda Duska, MD is currently running
Combination Therapy
for Advanced Cervical Cancer
This phase I/II trial tests the safety and effectiveness of receiving external beam radiation therapy (EBRT) and brachytherapy along with chemotherapy, consisting of cisplatin and paclitaxel, and immunotherapy, consisting of bevacizumab and pembrolizumab, for the treatment of patients with stage IVB cervical cancer. EBRT is type of radiation therapy that uses a machine to aim high-energy rays at the cancer from outside of the body. Brachytherapy, also known as internal radiation therapy, uses radioactive material placed directly into or near a tumor to kill tumor cells. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Paclitaxel is in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. A monoclonal antibody, such as pembrolizumab, is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Giving EBRT and brachytherapy along with chemotherapy and immunotherapy may be a safe and effective way to treat patients with stage IVB cervical cancer.
Recruiting1 award Phase 1 & 24 criteria
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 210 criteria
More about Linda Duska, MD
Clinical Trial Related5 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Linda Duska, MD has experience with
- Paclitaxel
- Bevacizumab
- Carboplatin
- Niraparib
- Oregovomab
- Pegylated Liposomal Doxorubicin Hydrochloride
Breakdown of trials Linda Duska, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Endometrial Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Linda Duska, MD specialize in?
Linda Duska, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are ARID1A positive.
Is Linda Duska, MD currently recruiting for clinical trials?
Yes, Linda Duska, MD is currently recruiting for 10 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Linda Duska, MD has studied deeply?
Yes, Linda Duska, MD has studied treatments such as Paclitaxel, Bevacizumab, Carboplatin.
What is the best way to schedule an appointment with Linda Duska, MD?
Apply for one of the trials that Linda Duska, MD is conducting.
What is the office address of Linda Duska, MD?
The office of Linda Duska, MD is located at: University of Virginia Cancer Center, Charlottesville, Virginia 22903 United States. This is the address for their practice at the University of Virginia Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.